Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of the SureX HPV genotyping test for the detection of high-risk HPV in cervical cancer screening.

Virology journal - 9 Nov 2020

Wei Baojun, Mei Ping, Huang Shengkai, Yu Xueting, Zhi Tong, Wang Guojing, Xu Xiaotian, Xiao Lin, Dong Xin, Cui Wei

Abstract excerpt

BACKGROUND: The SureX HPV genotyping test (SureX HPV test), which targets the human papillomavirus (HPV) E6/E7 genes was compared with the Cobas 4800 and Venus HPV tests for detecting 14 high-risk HPV (HR-HPV) types in clinical referral and follow-up patients to evaluate its value for cervical cancer screening. METHODS: Two different populations were enrolled in the study. The first population comprised 185 cases...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Early Detection of Cancer
Share to Mass Screening

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Molecular Diagnostic Techniques

Share to Papillomaviridae

Share to Reagent Kits, Diagnostic

Share to Uterine Cervical Dysplasia

Share to Uterine Cervical Neoplasms

Share to Vaginal Smears

Source

Open in PubMed Open full text

Identifiers

PMID: 33168022
DOI: 10.1186/s12985-020-01417-8
PMCID: PMC7650185

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of the SureX HPV genotyping test for the detection of high-risk HPV in cervical cancer screening.PMID 33168022Read ↗

Evaluation of the SureX HPV Genotyping Test for the Detection of High-Risk HPV in Cervical Cancer ScreeningSemantic proximity Read ↗

Comparison of a Newly Developed HPV Genotyping Assay (Mojin HPV Kit) with Cobas 4800 HPV Test for Detection of High-Risk HPV in Specimens Collected in SurePath Solution.Semantic proximity Read ↗

Clinical validation of full genotyping CLART® HPV4S assay on SurePath and ThinPrep collected screening samples according to the International Guidelines for Human Papillomavirus Test Requirements for Cervical ScreeningSemantic proximity Read ↗

Validation of cobas 4800 HPV assay in SurePath Papanicolaou specimens for cervical cancer screening.Semantic proximity Read ↗

Head-to-head comparison of the MyGene human papillomavirus-sexually transmitted infection assay versus the Cobas 4800 human papillomavirus test for detecting high-grade cervical intraepithelial neoplasia.Semantic proximity Read ↗

Clinical validation of the Cobas 4800 HPV assay using cervical samples in SurePath medium under the VALGENT4 framework.Semantic proximity Read ↗

Clinical validation of full genotyping CLART® HPV4S assay on SurePath and ThinPrep collected screening samples according to the international guidelines for human papillomavirus test requirements for cervical screening.Semantic proximity Read ↗

Comparison of the performance of Anyplex II HPV HR, the Cobas 4800 human papillomavirus test and Hybrid Capture 2.Semantic proximity Read ↗

Clinical validation of Anyplex™ II HPV HR Detection according to the guidelines for HPV test requirements for cervical cancer screening.Semantic proximity Read ↗

Evaluation of an E6/E7 PCR-capillary electrophoresis fragment analysis in the genotyping of human papillomavirus in archival FFPE samples of oropharyngeal cancer.Semantic proximity Read ↗

Analytical performance of cervista HPV 16/18 in SurePath pap specimens.Semantic proximity Read ↗

Clinical Performance of the Full Genotyping Agena MassARRAY HPV Assay Using SurePath Screening Samples within the VALGENT4 Framework.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.